Corvus Pharmaceuticals Free Cash Flow (Quarterly) Analysis

Corvus Pharmaceuticals Inc (CRVS)

1.92 +0.19 (+10.98%) USD | NASDAQ | May 03, 16:00

2.05 +0.13 (+6.77%) After-Hours: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-5.167M
September 30, 2023	-5.434M
June 30, 2023	-5.223M
March 31, 2023	-8.145M
December 31, 2022	-7.547M
September 30, 2022	-7.194M
June 30, 2022	-6.127M
March 31, 2022	-6.424M
December 31, 2021	-6.856M
September 30, 2021	-8.425M
June 30, 2021	-12.65M
March 31, 2021	-8.787M
December 31, 2020	-8.207M
September 30, 2020	-7.808M
June 30, 2020	-9.486M
March 31, 2020	-9.353M
December 31, 2019	-8.515M
September 30, 2019	-10.61M

Date	Value
June 30, 2019	-9.214M
March 31, 2019	-9.006M
December 31, 2018	-8.392M
September 30, 2018	-10.96M
June 30, 2018	-10.94M
March 31, 2018	-11.05M
December 31, 2017	-10.97M
September 30, 2017	-10.82M
June 30, 2017	-11.83M
March 31, 2017	-12.86M
December 31, 2016	-10.02M
September 30, 2016	-6.784M
June 30, 2016	-7.002M
March 31, 2016	-6.25M
December 31, 2015	-4.802M
September 30, 2015	-3.358M
June 30, 2015	-2.267M
March 31, 2015	-2.648M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-12.65M

Minimum

Jun 2021

-5.167M

Maximum

Dec 2023

-7.956M

Average

-8.145M

Median

Mar 2023

Free Cash Flow (Quarterly) Benchmarks